Isolated Central Nervous System Involvement after Brentuximab Vedotin Treatment for HIV-Positive ALK-Negative Anaplastic Large Cell Lymphoma

<div>Diffuse infiltration of atypical lymphoid cells observed via hematoxylin and eosin (HE) staining (a) (bar = 20 <i>μ</i>m). Immunohistochemical staining of the atypical lymphoid cells was positive for CD3 (b), CD30 (c), and negative for anaplastic lymphoma kinase (ALK) (d) (bar = 50 <i>μ</i>m).</div>

Case Reports in Hematology

fig1

Figure 1

Figure 1: Isolated Central Nervous System Involvement after Brentuximab Vedotin Treatment for HIV-Positive ALK-Negative Anaplastic Large Cell Lymphoma 

Figure 1 | Isolated Central Nervous System Involvement after Brentuximab Vedotin Treatment for HIV-Positive ALK-Negative Anaplastic Large Cell Lymphoma 